RBSH
REBUS HLDGS INC by REBUS HLDGS INC. (RBSH)
$00
About REBUS HLDGS INC by REBUS HLDGS INC. (RBSH)
Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
3,200
Dividend yield
0.00%
Volume
--
Avg. volume
1,205
P/E ratio
--
REBUS HLDGS INC by REBUS HLDGS INC. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
3,200
Dividend yield
0.00%
Volume
--
Avg. volume
1,205
P/E ratio
--